Inhibiting TRPC6 degradation prevents ischemic brain damage, with a reduction in infarct volume at 24 hours after reperfusion, an improvement in behavior performance, and a lower mortality within 35 days after ischemia [57]. The gene discussed is TRPC6; the disease is ischemia.